nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—Skin necrosis—Carmustine—malignant glioma	0.0689	0.0689	CcSEcCtD
Metolazone—Petechiae—Temozolomide—malignant glioma	0.0283	0.0283	CcSEcCtD
Metolazone—Skin exfoliation—Carmustine—malignant glioma	0.023	0.023	CcSEcCtD
Metolazone—Neuropathy—Carmustine—malignant glioma	0.0226	0.0226	CcSEcCtD
Metolazone—Skin exfoliation—Temozolomide—malignant glioma	0.0222	0.0222	CcSEcCtD
Metolazone—Neuropathy—Temozolomide—malignant glioma	0.0218	0.0218	CcSEcCtD
Metolazone—Swelling—Carmustine—malignant glioma	0.0198	0.0198	CcSEcCtD
Metolazone—Vascular purpura—Temozolomide—malignant glioma	0.0189	0.0189	CcSEcCtD
Metolazone—Hyponatraemia—Carmustine—malignant glioma	0.0175	0.0175	CcSEcCtD
Metolazone—Purpura—Temozolomide—malignant glioma	0.0175	0.0175	CcSEcCtD
Metolazone—Hypokalaemia—Carmustine—malignant glioma	0.0159	0.0159	CcSEcCtD
Metolazone—Dry skin—Temozolomide—malignant glioma	0.0155	0.0155	CcSEcCtD
Metolazone—Hypokalaemia—Temozolomide—malignant glioma	0.0154	0.0154	CcSEcCtD
Metolazone—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.0152	0.0152	CcSEcCtD
Metolazone—Abdominal distension—Temozolomide—malignant glioma	0.0147	0.0147	CcSEcCtD
Metolazone—Hyperglycaemia—Carmustine—malignant glioma	0.0136	0.0136	CcSEcCtD
Metolazone—Erectile dysfunction—Temozolomide—malignant glioma	0.0134	0.0134	CcSEcCtD
Metolazone—Photosensitivity reaction—Temozolomide—malignant glioma	0.0133	0.0133	CcSEcCtD
Metolazone—Neuropathy peripheral—Carmustine—malignant glioma	0.0132	0.0132	CcSEcCtD
Metolazone—Hyperglycaemia—Temozolomide—malignant glioma	0.0132	0.0132	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.0129	0.0129	CcSEcCtD
Metolazone—Neuropathy peripheral—Temozolomide—malignant glioma	0.0127	0.0127	CcSEcCtD
Metolazone—Hepatitis—Temozolomide—malignant glioma	0.0117	0.0117	CcSEcCtD
Metolazone—Erythema multiforme—Temozolomide—malignant glioma	0.011	0.011	CcSEcCtD
Metolazone—Tinnitus—Temozolomide—malignant glioma	0.0109	0.0109	CcSEcCtD
Metolazone—Chills—Temozolomide—malignant glioma	0.0105	0.0105	CcSEcCtD
Metolazone—Back pain—Carmustine—malignant glioma	0.0102	0.0102	CcSEcCtD
Metolazone—Dysgeusia—Temozolomide—malignant glioma	0.00995	0.00995	CcSEcCtD
Metolazone—Vision blurred—Carmustine—malignant glioma	0.00991	0.00991	CcSEcCtD
Metolazone—Back pain—Temozolomide—malignant glioma	0.00983	0.00983	CcSEcCtD
Metolazone—Anaemia—Carmustine—malignant glioma	0.00972	0.00972	CcSEcCtD
Metolazone—Agitation—Carmustine—malignant glioma	0.00967	0.00967	CcSEcCtD
Metolazone—Vision blurred—Temozolomide—malignant glioma	0.00958	0.00958	CcSEcCtD
Metolazone—Ill-defined disorder—Temozolomide—malignant glioma	0.00943	0.00943	CcSEcCtD
Metolazone—Leukopenia—Carmustine—malignant glioma	0.00941	0.00941	CcSEcCtD
Metolazone—Anaemia—Temozolomide—malignant glioma	0.00939	0.00939	CcSEcCtD
Metolazone—Agitation—Temozolomide—malignant glioma	0.00934	0.00934	CcSEcCtD
Metolazone—Malaise—Temozolomide—malignant glioma	0.00917	0.00917	CcSEcCtD
Metolazone—Vertigo—Temozolomide—malignant glioma	0.00913	0.00913	CcSEcCtD
Metolazone—Leukopenia—Temozolomide—malignant glioma	0.0091	0.0091	CcSEcCtD
Metolazone—Hypertension—Carmustine—malignant glioma	0.00908	0.00908	CcSEcCtD
Metolazone—Palpitations—Temozolomide—malignant glioma	0.00898	0.00898	CcSEcCtD
Metolazone—Chest pain—Carmustine—malignant glioma	0.00895	0.00895	CcSEcCtD
Metolazone—Anxiety—Carmustine—malignant glioma	0.00892	0.00892	CcSEcCtD
Metolazone—Cough—Temozolomide—malignant glioma	0.00887	0.00887	CcSEcCtD
Metolazone—Hypertension—Temozolomide—malignant glioma	0.00878	0.00878	CcSEcCtD
Metolazone—Arthralgia—Temozolomide—malignant glioma	0.00865	0.00865	CcSEcCtD
Metolazone—Anxiety—Temozolomide—malignant glioma	0.00862	0.00862	CcSEcCtD
Metolazone—Discomfort—Temozolomide—malignant glioma	0.00855	0.00855	CcSEcCtD
Metolazone—Dry mouth—Temozolomide—malignant glioma	0.00846	0.00846	CcSEcCtD
Metolazone—Thrombocytopenia—Carmustine—malignant glioma	0.0084	0.0084	CcSEcCtD
Metolazone—Anorexia—Carmustine—malignant glioma	0.00818	0.00818	CcSEcCtD
Metolazone—Thrombocytopenia—Temozolomide—malignant glioma	0.00812	0.00812	CcSEcCtD
Metolazone—Anorexia—Temozolomide—malignant glioma	0.00791	0.00791	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00782	0.00782	CcSEcCtD
Metolazone—Insomnia—Carmustine—malignant glioma	0.00776	0.00776	CcSEcCtD
Metolazone—Paraesthesia—Carmustine—malignant glioma	0.00771	0.00771	CcSEcCtD
Metolazone—Somnolence—Carmustine—malignant glioma	0.00763	0.00763	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00756	0.00756	CcSEcCtD
Metolazone—Insomnia—Temozolomide—malignant glioma	0.0075	0.0075	CcSEcCtD
Metolazone—Decreased appetite—Carmustine—malignant glioma	0.00746	0.00746	CcSEcCtD
Metolazone—Paraesthesia—Temozolomide—malignant glioma	0.00745	0.00745	CcSEcCtD
Metolazone—Somnolence—Temozolomide—malignant glioma	0.00737	0.00737	CcSEcCtD
Metolazone—Constipation—Carmustine—malignant glioma	0.00734	0.00734	CcSEcCtD
Metolazone—Pain—Carmustine—malignant glioma	0.00734	0.00734	CcSEcCtD
Metolazone—Dyspepsia—Temozolomide—malignant glioma	0.0073	0.0073	CcSEcCtD
Metolazone—Decreased appetite—Temozolomide—malignant glioma	0.00721	0.00721	CcSEcCtD
Metolazone—Fatigue—Temozolomide—malignant glioma	0.00715	0.00715	CcSEcCtD
Metolazone—Pain—Temozolomide—malignant glioma	0.00709	0.00709	CcSEcCtD
Metolazone—Constipation—Temozolomide—malignant glioma	0.00709	0.00709	CcSEcCtD
Metolazone—Feeling abnormal—Carmustine—malignant glioma	0.00707	0.00707	CcSEcCtD
Metolazone—Gastrointestinal pain—Carmustine—malignant glioma	0.00702	0.00702	CcSEcCtD
Metolazone—Feeling abnormal—Temozolomide—malignant glioma	0.00684	0.00684	CcSEcCtD
Metolazone—Abdominal pain—Carmustine—malignant glioma	0.00679	0.00679	CcSEcCtD
Metolazone—Gastrointestinal pain—Temozolomide—malignant glioma	0.00678	0.00678	CcSEcCtD
Metolazone—Urticaria—Temozolomide—malignant glioma	0.00659	0.00659	CcSEcCtD
Metolazone—Abdominal pain—Temozolomide—malignant glioma	0.00656	0.00656	CcSEcCtD
Metolazone—Hypersensitivity—Carmustine—malignant glioma	0.00632	0.00632	CcSEcCtD
Metolazone—Asthenia—Carmustine—malignant glioma	0.00616	0.00616	CcSEcCtD
Metolazone—Hypersensitivity—Temozolomide—malignant glioma	0.00611	0.00611	CcSEcCtD
Metolazone—Asthenia—Temozolomide—malignant glioma	0.00595	0.00595	CcSEcCtD
Metolazone—Diarrhoea—Carmustine—malignant glioma	0.00587	0.00587	CcSEcCtD
Metolazone—Pruritus—Temozolomide—malignant glioma	0.00587	0.00587	CcSEcCtD
Metolazone—Dizziness—Carmustine—malignant glioma	0.00568	0.00568	CcSEcCtD
Metolazone—Diarrhoea—Temozolomide—malignant glioma	0.00568	0.00568	CcSEcCtD
Metolazone—Dizziness—Temozolomide—malignant glioma	0.00549	0.00549	CcSEcCtD
Metolazone—Vomiting—Carmustine—malignant glioma	0.00546	0.00546	CcSEcCtD
Metolazone—Rash—Carmustine—malignant glioma	0.00541	0.00541	CcSEcCtD
Metolazone—Dermatitis—Carmustine—malignant glioma	0.00541	0.00541	CcSEcCtD
Metolazone—Headache—Carmustine—malignant glioma	0.00538	0.00538	CcSEcCtD
Metolazone—Vomiting—Temozolomide—malignant glioma	0.00527	0.00527	CcSEcCtD
Metolazone—Rash—Temozolomide—malignant glioma	0.00523	0.00523	CcSEcCtD
Metolazone—Dermatitis—Temozolomide—malignant glioma	0.00523	0.00523	CcSEcCtD
Metolazone—Headache—Temozolomide—malignant glioma	0.0052	0.0052	CcSEcCtD
Metolazone—Nausea—Carmustine—malignant glioma	0.0051	0.0051	CcSEcCtD
Metolazone—Nausea—Temozolomide—malignant glioma	0.00493	0.00493	CcSEcCtD
